SureTrader
Home > Boards > US OTC > Medical - Drugs > Ocata Therapeutics Inc. (OCAT)

ACTC 2014!!!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Trader Joey Member Profile
 
Followed By 6
Posts 833
Boards Moderated 0
Alias Born 02/09/11
160x600 placeholder
Advertisement
Ocata Therapeutics Added to Russell 2000, 3000, Global and Microcap Indices "Business Wire" - 6/30/2015 8:00:00 AM
Ocata Therapeutics Announces Positive Results Reported in a Late Breaking Abstract at the Annual Meeting of the International... "Business Wire" - 6/24/2015 9:15:00 AM
Ocata Therapeutics to Ring the NASDAQ Stock Market Opening Bell on June 24, 2015 "Business Wire" - 6/18/2015 8:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/17/2015 5:06:10 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 6/17/2015 5:03:24 PM
Ocata Therapeutics Announces Pricing of $30 Million Offering of Common Stock and Warrants "Business Wire" - 6/16/2015 8:13:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 6/11/2015 4:52:32 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 6/11/2015 4:50:20 PM
Ocata Therapeutics Receives Important New U.S. Patent for its RPE Therapy for Macular Degenerative Diseases "Business Wire" - 6/2/2015 8:01:00 AM
Ocata Therapeutics Receives Three New U.S. Patents for its RPE Therapy for Macular Degenerative Diseases "Business Wire" - 5/26/2015 8:54:00 AM
Ocata Therapeutics to Present at the Jefferies 2015 Global Healthcare Conference "Business Wire" - 5/18/2015 8:00:00 AM
Dr Robert Lanza, Chief Scientific Officer of Ocata Therapeutics to be a Featured Speaker at The Common Good Forum "Business Wire" - 5/11/2015 9:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/7/2015 4:27:13 PM
Ocata Therapeutics to Host Conference Call and Webcast to Provide Corporate Update for the First Quarter of 2015 "Business Wire" - 5/4/2015 8:00:00 AM
Ocata Therapeutics Announces Positive Results in Treating Macular Degeneration Using Fully Differentiated Stem Cell-Derived R... "Business Wire" - 4/30/2015 12:30:00 PM
Dr Robert Lanza, Chief Scientific Officer of Ocata Therapeutics to Deliver Opening Address at the Massachusetts State Science... "Business Wire" - 4/28/2015 9:02:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 4/28/2015 8:21:25 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 4/28/2015 6:01:37 AM
EDISON EQUITY RESEARCH - OCATA THERAPEUTICS "InvestorsHub NewsWire" - 4/17/2015 10:17:33 AM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 4/10/2015 5:20:31 PM
Securities Registration Statement (simplified Form) (s-3/a) "Edgar (US Regulatory)" - 4/3/2015 5:13:13 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/1/2015 4:20:34 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/1/2015 4:20:07 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/1/2015 4:19:43 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/1/2015 4:19:43 PM
Trader Joey   Wednesday, 12/18/13 11:46:27 PM
Re: A deleted message
Post # of 85864 
ACTC 2014!!!

Maybe they will be saying this in 2014:

"We continue to pay our loyal retail stockholders with the constant rise on their shares of common
stock, enabling us to use our cash resources to fund there quarterly dividend”


I am looking forward too ACTC in 2014….. lots of positives coming up..... going to get very interesting.....

BYE BYE _____A______?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist